Abstract
With the exception of steroid myopathy, which is almost invariably iatrogenic (Swash and Schwartz 1983a) (see Chap. 18), drug-induced myopathies are relatively rare. Muscle is thus relatively less susceptible to drug effects than peripheral nerve (see Chap. 11). The most useful, practical classification of drug-induced myopathies is by mode of clinical presentation. This approach was adopted by Lane and Mastaglia (1978). The diversity of the syndromes tends to lead to a complex classification (Kakulas and Mastaglia 1992) but this overlaps with diseases having a recognised metabolic basis in which drug effects play a causative role, e.g. malignant hyperpyrexia (Table 19.1). These syndromes to some extent overlap.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
